Skip to main content
NCBI home page
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 2008 Jan 16;22(1):77–85. doi: 10.1002/jcla.20214

Mass spectroscopic characteristics of low molecular weight proteins extracted from calcium oxalate stones: preliminary study

Wen‐Chi Chen 1,2,3,✉, Chein‐Cheng Lai 2, Yu‐Hsin Tsai 4, Wei‐Yong Lin 2,3, Fuu‐Jen Tsai 2,5
PMCID: PMC6648977  PMID: 18200570

Abstract

It is believed that boundary compositions of matrix proteins might play a role in stone formation; however, few proteomic studies concerning matrix proteins in urinary stones have been conducted. In this study, we extracted low molecular weight proteins from calcium oxalate stones and measured their characteristic patterns by mass spectroscopy. A total of 10 stones were surgically removed from patients with urolithiasis. Proteins were extracted from the stones and identified by one‐dimensional electrophoresis (sodium dodecyl sulfate buffer [SDS]–polyacrylamide gel electrophoresis [SDS‐PAGE]). After in‐gel digest, samples were analyzed by the surface‐enhanced laser desorption ionization‐time of flight (SELDI‐TOF) technique. The peptide sequences were analyzed from the data of mass spectroscopy. Proteins were identified from Database Search (SwissProt Protein Database; Swiss Institute of Bioinformatics; http://www.expasy.org/sprot) on a MASCOT server (Matrix Science Ltd.; http://www.matrixscience.com). A total of three bands of proteins (27, 18, and 14 kDa) were identified from SDS‐PAGE in each stone sample. A database search (SwissProt) on a MASCOT server revealed that the most frequently seen proteins from band 1 (27 kDa) were leukocyte elastase precursor, cathepsin G precursor, azurocidin precursor, and myeloblastin precursor (EC 3.4.21.76) (leukocyte proteinase 3); band 2 (18 kDa) comprised calgranulin B, eosinophil cationic protein precursor, and lysozyme C precursor; band 3 (14 kDa) showed neutrophil defensin 3 precursor, calgranulin A, calgranulin C, and histone H4. The modifications and deamidations found from the mass pattern of these proteins may provide information for the study of matrix proteins. Various lower molecular weight proteins can be extracted from calcium oxalate stones. The characteristic patterns and their functions of those proteins should be further tested to investigate their roles in stone formation. J. Clin. Lab. Anal. 22:77–85, 2008. © 2008 Wiley‐Liss, Inc.

Keywords: calcium oxalate, matrix protein, matrix‐assisted laser desorption‐time of flight mass spectrometry (MALDI‐TOF‐MS), surface‐enhanced laser desorption ionization‐time of flight mass spectrometry (SELDI‐TOF‐MS), leukocyte elastase precursor

REFERENCES

  • 1. Smith LH. Abnormal biomineralization In: Nancollas GH, editor. Biological mineralization and demineralization. New York: Springer‐Veralg; 1982. [Google Scholar]
  • 2. Li X, Zhang D, Lynch‐Holm VJ, Okita TW, Franceschi VR. Isolation of a crystal matrix protein associated with calcium oxalate precipitation in vacuoles of specialized cells. Plant Physiol 2003;133:549–559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Nakagawa Y, Margolis HC, Yokoyama S, Kezdy FJ, Kaiser ET, Coe FL. Purification and characterization of a calcium oxalate monohydrate crystal growth inhibitor from human kidney tissue culture medium. J Biol Chem 1981;256:3936–3944. [PubMed] [Google Scholar]
  • 4. Khan SR, Kok DJ. Modulators of urinary stone formation. Front Biosci 2004;9:1450–1482. [DOI] [PubMed] [Google Scholar]
  • 5. Hess B, Meinhardt U, Zipperle L, Giovanoli R, Jaeger P. Simultaneous measurements of calcium oxalate crystal nucleation and aggregation: impact of various modifiers. Urol Res 1995;21:231–238. [DOI] [PubMed] [Google Scholar]
  • 6. Boyce WH. Organic matrix of human urinary concretions. Am J Med 1968;45:673–683. [DOI] [PubMed] [Google Scholar]
  • 7. Vermeulen OW, Lyon ES. Mechanisms of genesis and growth of calculi. Am J Med 1968;45:684–692. [DOI] [PubMed] [Google Scholar]
  • 8. Doyle IR, Marshall VR, Dawson CJ, Ryall RL. Calcium oxalate crystal matrix effect: the most potent macromolecular inhibitor of crystal growth and aggregation yet tested in undiluted human urine in vitro. Urol Res 1995;23:53–62. [DOI] [PubMed] [Google Scholar]
  • 9. Kumar V, Pena de la Vega L, Farell G, Lieske JC. Urinary macromolecular inhibition of crystal adhesion to renal epithelial cells is impaired in male stone formers. Kidney Int 2005;68:1784–1792. [DOI] [PubMed] [Google Scholar]
  • 10. Khan SR, Johnson JM, Peck AB, Cornelius JG, Glenton PA. Expression of osteopontin in rat kidneys: induction during ethylene glycol induced calcium oxalate nephrolithiasis. J Urol 2002;168:1173–1181. [DOI] [PubMed] [Google Scholar]
  • 11. Govindaraj A, Selvam R. Increased calcium oxalate crystal nucleation and aggregation by peroxidized protein of human kidney stone matrix and renal cells. Urol Res 2001;29:194–198. [DOI] [PubMed] [Google Scholar]
  • 12. Bennett J, Dretler SP, Selengut J, Orme‐Johnson WH. Identification of the calcium‐binding protein calgranulin in the matrix of struvite stones. J Endourol 1994;8:95–98. [DOI] [PubMed] [Google Scholar]
  • 13. Kommu S, Sharifi R, Edward S, Eeles R. Proteomics and urine analysis: a potential promising new tool in urology. BJU Int 2004;93:1172–1173. [DOI] [PubMed] [Google Scholar]
  • 14. Siddiqui AA, Sultana T, Buchholz NP, Waqar MA, Talati J. Proteins in renal stones and urine of stone formers. Urol Res 1998;26:383–388. [DOI] [PubMed] [Google Scholar]
  • 15. Gharahdaghi F, Weinberg CR, Meagher DA, Imai BS, Missche SM. Mass spectrometric identification of proteins from silver‐stained polyacrylamide gel: a method for the removal of silver ions to enhance sensitivity. Electrophoresis 1999;20:601–605. [DOI] [PubMed] [Google Scholar]
  • 16. Terry DE, Umstot E, Desiderio DM. Optimized sample‐processing time and peptide recovery for the mass spectrometric analysis of protein digests. J Am Soc Mass Spectrom 2004;15:784–794. [DOI] [PubMed] [Google Scholar]
  • 17. Expert Protein Analysis System (ExPASy) Proteomics Server. UniProtKB/Swiss‐Prot entry P05164. Myeloperoxidase [Precursor]. Available at: http://www.expasy.org/uniprot/P05164. Last accessed: 3 October 2007.
  • 18. Cadieux PA, Beiko DT, Watterson JD, et al. Surface‐enhanced laser desorption/ionization‐time‐of‐flight‐mass spectrometry (SELDI‐TOF‐MS): a new proteomic urinary test for patients with urolithiasis. J Clin Lab Anal 2004;18:170–175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Chutipongtanate S, Nakagawa Y, Sritippayawan S, et al. Identification of human urinary trefoil factor 1 as a novel calcium oxalate crystal growth inhibitor. J Clin Invest 2005;115:3613–3622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Aoki Y. Crystallization and characterization of a new protease in mitochondria of bone marrow cells. J Biol Chem 1978;253:2026–2032. [PubMed] [Google Scholar]
  • 21. Weinrauch Y, Drujan D, Shapiro SD, Weiss J, Zychlinsky Z. Neutrophil elastase targets virulence factors of enterobacteria. Nature 2002;417:91–94. [DOI] [PubMed] [Google Scholar]
  • 22. Heck LW, Rostand KS, Hunter FA, Bhown A. Isolation, characterization, and amino‐terminal amino acid sequence analysis of human neutrophil cathepsin G from normal donors. Anal Biochem 1986;158:217–227. [DOI] [PubMed] [Google Scholar]
  • 23. Morgan JG, Sukiennicki T, Pereira HA, Spitznagel JK, Guerra ME, Larrick JW. Cloning of the cDNA for the serine protease homolog CAP37/azurocidin, a microbicidal and chemotactic protein from human granulocytes. J Immunol 1991;147:3210–3214. [PubMed] [Google Scholar]
  • 24. Dorin JR, Novak M, Hill RE, Brock DJ, Secher DS, van Heyningen VA. Clue to the basic defect in cystic fibrosis from cloning the CF antigen gene. Nature 1987;326:614–617. [DOI] [PubMed] [Google Scholar]
  • 25. Guo J, Yang EC, Desouza L, et al. A strategy for high‐resolution protein identification in surface‐enhanced laser desorption/ionization mass spectrometry: calgranulin A and chaperonin 10 as protein markers for endometrial carcinoma. Proteomics 2005;5:1953–1966. [DOI] [PubMed] [Google Scholar]
  • 26. Bergsland KJ, Kelly JK, Coe BJ, Coe FL. Urine protein markers distinguish stone‐forming from non‐stone‐forming relatives of calcium stone formers. Am J Physiol Renal Physiol 2006;291:F530–F536. [DOI] [PubMed] [Google Scholar]
  • 27. Tawada T, Fujita K, Sakakura T, et al. Distribution of osteopontin and calprotectin as matrix protein in calcium‐containing stone. Urol Res 1999;27:238–242. [DOI] [PubMed] [Google Scholar]
  • 28. Kleinman JG, Wesson JA, Hughes J. Osteopontin and calcium stone formation. Nephron Physiol 2004;98:43–47. [DOI] [PubMed] [Google Scholar]
  • 29. Selvam R, Kalaiselvi P. Oxalate binding proteins in calcium oxalate nephrolithiasis. Urol Res 2003;31:242–256. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES